• Skip to content
  • Skip to footer
  • Accessibility options
University of Brighton
  • About us
  • Business and
    employers
  • Alumni and
    supporters
  • For
    students
  • For
    staff
  • Accessibility
    options
Open menu
Home
Home
  • Close
  • Study here
    • Get to know us
    • Why choose Brighton?
    • Explore our prospectus
    • Chat to our students
    • Ask us a question
    • Meet us
    • Open days and visits
    • Virtual tours
    • Applicant days
    • Meet us in your country
    • Campuses
    • Our campuses
    • Our city
    • Accommodation options
    • Our halls
    • Helping you find a home
    • What you can study
    • Find a course
    • Full A-Z course list
    • Explore our subjects
    • Our academic departments
    • How to apply
    • Undergraduate application process
    • Postgraduate application process
    • International student application process
    • Apprenticeships
    • Transfer from another university
    • International students
    • Clearing
    • Funding your time at uni
    • Fees and financial support
    • What's included in your fees
    • Brighton Boost – extra financial help
    • Advice and guidance
    • Advice for students
    • Guide for offer holders
    • Advice for parents and carers
    • Advice for schools and colleges
    • Supporting you
    • Your academic experience
    • Your wellbeing
    • Your career and employability
  • Research
    • Research and knowledge exchange
    • Research and knowledge exchange organisation
    • The Global Challenges
    • Centres of Research Excellence (COREs)
    • Research Excellence Groups (REGs)
    • Our research database
    • Information for business
    • Community University Partnership Programme (CUPP)
    • Postgraduate research degrees
    • PhD research disciplines and programmes
    • PhD funding opportunities and studentships
    • How to apply for your PhD
    • Research environment
    • Investing in research careers
    • Strategic plan
    • Research concordat
    • News, events, publications and films
    • Featured research and knowledge exchange projects
    • Research and knowledge exchange news
    • Inaugural lectures
    • Research and knowledge exchange publications and films
    • Academic staff search
  • About us
  • Business and employers
  • Alumni, supporters and giving
  • Current students
  • Staff
  • Accessibility
Search our site
Aerial view of the Moulsecoomb campus
About us
  • Your university
  • Governance and structure
  • Working with us
  • Statistics and legal
  • News and events
  • Contact us
  • News and events
    • News and events
    • News
    • Events
    • Coronavirus
    • Livestream
    • Open lectures
    • Term dates
  • News
    • News
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013

Nanoparticle research may improve tumour treatment

Researchers have been working on the development of a potentially life-saving treatment for one of the most malignant and aggressive brain tumours.

6 April 2020

Glioblastoma multiforme (GBM) accounts for half of all brain tumours and has a high recurrence rate, usually resulting in aggressive surgery plus chemotherapy and radiotherapy.

Now, researchers have proposed a new treatment using nanoparticles which deliver chemotherapeutic drugs and therapeutic antibodies directly to the cancer. In vitro experiments showed this can be significantly more efficacious and has the additional benefit of avoiding invasive surgery.

More research is needed before the new therapy can be given to patients but, the researchers said, it “…has the potential to revolutionise anti-cancer treatment by combining different killing strategies”.

Dr Irina Savina

Dr Irina Savina

The research project ‘GLIOMA’ was undertaken by Dr Sreejith Raveendran with the support of the Marie SkÅ‚odowska-Curie (MSC) programme, and is published by the European Commission’s CORDIS information service.

The project was coordinated by Dr Irina Savina, from the University of Brighton’s Biomaterials and Drug Delivery Research and Enterprise Group.

Dr Savina, senior lecturer in the School of Pharmacy and Biomolecular Science, said: “Administration of combinatorial therapies that include chemotherapeutic agents and immunogens is the way forward for cancer treatment; not only do you kill cancer cells, but you also establish durable immunological memory to prevent tumour recurrence.”

Back to top
  • Facebook
  • X logo
  • Instagram
  • TikTok
  • YouTube
  • LinkedIn icon

Contact us

University of Brighton
Mithras House
Lewes Road
Brighton
BN2 4AT

Main switchboard 01273 600900

Course enquiries

Sign up for updates

University contacts

Report a problem with this page

Quick links Quick links

  • Courses
  • Open days
  • Explore our prospectus
  • Academic departments
  • Academic staff
  • Professional services departments
  • Jobs
  • Privacy and cookie policy
  • Accessibility statement
  • Libraries
  • Term dates
  • Maps
  • Graduation
  • Site information
  • Online shop
  • The Student Contract

Information for Information for

  • Current students
  • International students
  • Media/press
  • Careers advisers/teachers
  • Parents/carers
  • Business/employers
  • Alumni/supporters
  • Suppliers
  • Local residents